UTHR UNITED THERAPEUTICS Corp
Price Chart
Executive Summary
Three top insiders at United Therapeutics (CEO, CFO, General Counsel) sold a combined ~$110K in open-market transactions over two days. The dollar amount is trivial relative to the company's $24.1B market cap (~0.0005%) and is consistent with routine stock-for-tax settlements after option exercises. The cluster pattern is weak — these are small, liquidity-driven sales, not a coordinated signal of deteriorating fundamentals.
Key Financial Metrics
Actionable Insight
Traders should treat this as routine and non-informative. The sales represent a tiny fraction of each executive's holdings and are paired with option exercises, suggesting tax- or diversification-driven dispositions. No bearish signal from this cluster. Monitor next quarterly filing for any shift in business momentum, but this insider activity alone does not warrant action.
Key Facts
- CEO Martine Rothblatt sold 47 shares for $26K on May 22 (open-market).
- CFO James Edgemond sold 40 shares for $22K on May 21 (open-market).
- General Counsel Paul Mahon sold 110 shares for $61K on May 21 (open-market).
- All three also exercised non-cash stock options or derivative conversions in the same window.
- Total open-market sales = ~$110K, or 0.0005% of the $24.1B market cap.
- No insider open-market purchases were reported in the cluster.
Financial Impact
Approximately $110,000 in insider sales — immaterial relative to $24.1B market cap.
Risk Factors
- Insider sales are small and likely liquidity-driven, but any unexpected acceleration in selling volume or pattern change in future filings would warrant closer scrutiny.
- The company has no current known catalysts or disclosures that would explain insider selling — absence of red flags is not a guarantee of continued stock performance.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1779828428370 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
today
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
Jun 4, 2026
1d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
Jun 4, 2026
1d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
Jun 3, 2026
2d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 29, 2026
7d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 28, 2026
8d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 27, 2026
9d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 26, 2026
10d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 26, 2026
10d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
|
May 22, 2026
14d ago
|
Insider Cluster
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access